• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过电子显微镜和图像分析确定的多药耐药P-糖蛋白在2.5纳米分辨率下的结构。

Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.

作者信息

Rosenberg M F, Callaghan R, Ford R C, Higgins C F

机构信息

Department of Biochemistry and Applied Molecular Biology, University of Manchester Institute of Science and Technology, P. O. Box 88, Manchester M60 1QD, United Kingdom.

出版信息

J Biol Chem. 1997 Apr 18;272(16):10685-94. doi: 10.1074/jbc.272.16.10685.

DOI:10.1074/jbc.272.16.10685
PMID:9099718
Abstract

P-glycoprotein (P-gp) is a member of the ATP binding cassette superfamily of active transporters and can confer multidrug resistance on cells and tumors by pumping chemotherapeutic drugs from the cytoplasm. P-gp was purified from CHrB30 cells and retained the ability to bind substrates and hydrolyze ATP. Labeling of P-gp with lectin-gold particles suggested it is monomeric. An initial structure of purified P-gp was determined to 2.5 nm resolution by electron microscopy and single particle image analysis of both detergent-solubilized and lipid-reconstituted protein. The structure was further refined by three dimensional reconstructions from single particle images and by Fourier projection maps of small two-dimensional crystalline arrays (unit cell parameters: a, 14.2 nm; b, 18.5 nm; and gamma, 91.6 degrees ). When viewed from above the membrane plane the protein is toroidal, with 6-fold symmetry and a diameter of about 10 nm. There is a large central pore of about 5 nm in diameter, which is closed at the inner (cytoplasmic) face of the membrane, forming an aqueous chamber within the membrane. An opening from this chamber to the lipid phase is present. The projection of the protein perpendicular to the membrane is roughly rectangular with a maximum depth of 8 nm and two 3-nm lobes exposed at the cytoplasmic face of the membrane, likely to correspond to the nucleotide binding domains. This study provides the first experimental insight into the three-dimensional architecture of any ATP binding cassette transporter.

摘要

P-糖蛋白(P-gp)是ATP结合盒超家族主动转运蛋白的成员之一,可通过将化疗药物泵出细胞质,赋予细胞和肿瘤多药耐药性。P-糖蛋白从CHrB30细胞中纯化得到,保留了结合底物和水解ATP的能力。用凝集素-金颗粒标记P-糖蛋白表明它是单体。通过电子显微镜以及对去污剂增溶和脂质重构蛋白的单颗粒图像分析,确定了纯化的P-糖蛋白的初始结构,分辨率为2.5纳米。通过单颗粒图像的三维重建以及小二维晶体阵列的傅里叶投影图(晶胞参数:a,14.2纳米;b,18.5纳米;γ,91.6度)进一步优化了该结构。从膜平面上方观察时,该蛋白呈环形,具有六重对称性,直径约为10纳米。有一个直径约5纳米的大中央孔,该孔在膜的内侧(细胞质)表面封闭,在膜内形成一个水相腔室。存在从该腔室到脂质相的开口。垂直于膜的蛋白投影大致呈矩形,最大深度为8纳米,在膜的细胞质表面有两个3纳米的叶,可能对应于核苷酸结合结构域。这项研究首次对任何ATP结合盒转运蛋白的三维结构提供了实验性见解。

相似文献

1
Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.通过电子显微镜和图像分析确定的多药耐药P-糖蛋白在2.5纳米分辨率下的结构。
J Biol Chem. 1997 Apr 18;272(16):10685-94. doi: 10.1074/jbc.272.16.10685.
2
Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding.哺乳动物多药耐药性P-糖蛋白的三维结构显示,核苷酸结合后跨膜结构域发生了主要的构象变化。
J Biol Chem. 2003 Mar 7;278(10):8294-9. doi: 10.1074/jbc.M211758200. Epub 2002 Dec 25.
3
Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.在转运ATP酶循环过程中P-糖蛋白跨膜结构域的重新包装。
EMBO J. 2001 Oct 15;20(20):5615-25. doi: 10.1093/emboj/20.20.5615.
4
The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.在P-糖蛋白的转运循环中,长春碱结合位点呈现高亲和力和低亲和力两种构象。
Biochemistry. 2001 Dec 25;40(51):15733-42. doi: 10.1021/bi011211z.
5
The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis.多药耐药蛋白1(MRP1/ABCC1)的结构、结晶与单颗粒分析。
J Biol Chem. 2001 May 11;276(19):16076-82. doi: 10.1074/jbc.M100176200. Epub 2001 Jan 22.
6
The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.P-糖蛋白的ATP酶及ATP结合功能——与特定磷脂相互作用的调节作用
Eur J Biochem. 1998 Aug 15;256(1):170-8. doi: 10.1046/j.1432-1327.1998.2560170.x.
7
The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface.P-糖蛋白的功能纯化依赖于脂质-蛋白质界面的维持。
Biochim Biophys Acta. 1997 Sep 4;1328(2):109-24. doi: 10.1016/s0005-2736(97)00079-5.
8
Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis.枯草芽孢杆菌同源二聚体ATP结合盒转运蛋白YvcC的冷冻电镜三维结构。
J Mol Biol. 2002 Feb 1;315(5):1075-85. doi: 10.1006/jmbi.2001.5309.
9
Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.线虫多药外排转运蛋白 P-糖蛋白的晶体结构
Nature. 2012 Oct 25;490(7421):566-9. doi: 10.1038/nature11448. Epub 2012 Sep 23.
10
Projection structure of P-glycoprotein by electron microscopy. Evidence for a closed conformation of the nucleotide binding domains.通过电子显微镜观察P-糖蛋白的投射结构。核苷酸结合域封闭构象的证据。
J Biol Chem. 2002 Oct 18;277(42):40125-31. doi: 10.1074/jbc.M206871200. Epub 2002 Aug 5.

引用本文的文献

1
Mapping the Role of P-gp in Multidrug Resistance: Insights from Recent Structural Studies.绘制P-糖蛋白在多药耐药中的作用:近期结构研究的见解
Int J Mol Sci. 2025 Apr 28;26(9):4179. doi: 10.3390/ijms26094179.
2
Oligomerization of drug transporters: Forms, functions, and mechanisms.药物转运体的寡聚化:形式、功能及机制
Acta Pharm Sin B. 2024 May;14(5):1924-1938. doi: 10.1016/j.apsb.2024.01.007. Epub 2024 Jan 20.
3
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery.
ABCB1 和 ABCG2 在血脑屏障中的调控:改善脑内药物递送的潜在新靶点。
Pharmacol Rev. 2023 Sep;75(5):815-853. doi: 10.1124/pharmrev.120.000025. Epub 2023 Mar 27.
4
Preclinical studies of the triazolo[1,5-]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor.三唑并[1,5-]嘧啶衍生物WS-716作为一种高效、特异性且口服活性的P-糖蛋白(P-gp)抑制剂的临床前研究。
Acta Pharm Sin B. 2022 Aug;12(8):3263-3280. doi: 10.1016/j.apsb.2022.03.023. Epub 2022 Apr 2.
5
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.基于乳腺癌耐药蛋白(BCRP)及P-糖蛋白/乳腺癌耐药蛋白(P-gp/BCRP)双靶点的多药耐药调节剂研究的最新进展
Cancer Drug Resist. 2019 Sep 19;2(3):710-743. doi: 10.20517/cdr.2019.31. eCollection 2019.
6
Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4.过表达 BCRP、MRP1、MRP2、MRP3 和 MRP4 的 SN38 耐药 T47D 乳腺癌细胞亚系的表征。
BMC Cancer. 2022 Apr 23;22(1):446. doi: 10.1186/s12885-022-09446-y.
7
Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations.人 P-糖蛋白(ABCB1)的结构-功能关系:来自分子动力学模拟的见解。
Int J Mol Sci. 2021 Dec 29;23(1):362. doi: 10.3390/ijms23010362.
8
Structure of ABCB1/P-Glycoprotein in the Presence of the CFTR Potentiator Ivacaftor.在囊性纤维化跨膜传导调节因子(CFTR)增强剂依伐卡托存在的情况下ABCB1/ P-糖蛋白的结构
Membranes (Basel). 2021 Nov 25;11(12):923. doi: 10.3390/membranes11120923.
9
Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.天然次生代谢产物克服癌症多药耐药性的多种分子机制
Front Pharmacol. 2021 May 21;12:658513. doi: 10.3389/fphar.2021.658513. eCollection 2021.
10
The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.金纳米颗粒克服 P-糖蛋白介导的多药耐药性的临界尺寸。
Nanoscale. 2020 Aug 21;12(31):16451-16461. doi: 10.1039/d0nr03226c. Epub 2020 Jun 17.